Protective effects of Yindanxinnaotong capsule in a rat model of myocardial ischemia/reperfusion injury

Journal of Traditional Chinese Medicine

Volumn 34, Issue 6, 2014, Pages 699-709

  Wang, Wandan ^a   Wang, Lan ^a   Yang, Hongjun ^a   Wang, Jianlu ^a   Yin, Xiaojie ^a   Xu, Haiyu ^a   Cheng, Long ^b   Liang, Rixin ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Components compatibility; Myocardial ischemia; Reperfusion; Yindanxinnaotong capsule

Indexed keywords

CARDIAC AGENT; CHINESE DRUG; CREATINE KINASE MB; GINKGO BILOBA EXTRACT; HYDROGEN PEROXIDE; INTERLEUKIN 18; INTERLEUKIN 1BETA; LACTATE DEHYDROGENASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR 4; TROPONIN T; UNCLASSIFIED DRUG; YINDANXINNAOTONG; HERBACEOUS AGENT; INTERLEUKIN 8; MICROCAPSULE; PROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOWN REGULATION; DRUG MECHANISM; ELECTROCARDIOGRAM; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HYPOXIA; IN VITRO STUDY; ISOLATED HEART; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REOXYGENATION; REPERFUSION INJURY; SALVIA; SALVIA MILTIORRHIZA; WESTERN BLOTTING; ADMINISTRATION AND DOSAGE; ANIMAL; DISEASE MODEL; HEART MUSCLE; HUMAN; METABOLISM; MICROCAPSULE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

ANIMALS; CAPSULES; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-8; MALE; MALONDIALDEHYDE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

EID: 84925228336     PISSN: 02552922     EISSN: 2589451X     Source Type: Journal    
DOI: 10.1016/s0254-6272(15)30085-6     Document Type: Article

References (16)

1. Ji WN, Yang YN. Advances of treatment for myocardial ischemia reperfusion injury. Xin Xue Guan Bing Xue Jin Zhan 2011; 32(3): 432-435
2. Xie YJ, Huang W. Progress of toll-like receptor 2 and 4 in myocardial ischemia/reperfusion injury. Xin Xue Guan Bing Xue Jin Zhan 2013; 34(2): 240-243
3. Zhao XY. Aspirin combined with Yindanxinnaotong capsule to treat unstable angina pectoris of coronary heart disease in 30 cases. Zhong Xi Jie He Xin Nao Xue Huan Bing Za Zhi 2011; 9(9): 1124.
4. Zhou BY. The research progress and application of Yindanxinnaotong capsule on heart and kidney syndrome. Zhong Guo Xian Dai Yao Wu Ying Yong 2012; 6(8): 130-131.
5. Gao D, Zhang L, Dhillon R., Hong TT, Shaw RM, Zhu J. Dynasore protects mitochondria and improves cardiac lus-itropy in Langendorff perfused mouse heart. PLoS One 2013; 8(4): e60967.
6. Wei L, Wu RB, Yang C.M., Zheng SY, Yu XY. Polymerized placenta hemoglobin attenuates cold ischemia/reperfusion injury in isolated rat heart. Microvasc Res 2011; 82(3): 430-438.
7. Wang L, Lv DM, Liang R.X., Huang LQ, Yuan Y. Protection effect of salvia miltiorrhiza hairy root on rat hearts after myocardial ischemia-reperfusion. Zhong Guo Zhong Yao Za Zhi 2009; 34(14): 1841-1851.
8. Zhou YZ, Ma ZQ. Pharmacy mathematical statistics. Beijing: Science Press, 2004: 184-189.
9. Quan W, Yin Y, Xi M., et al. Antioxidant properties of magnesium lithospermate B contribute to the cardio-protection against myocardial ischemia/reperfusion injury in vivo and in vitro. J Tradit Chin Med 2013, 33(1): 85-91.
10. Zhang F, Huang B, Zhao Y., et al. BNC protects H9c2 cardiomyoblasts from H2O2-induced oxidative injury through ERK1/2 signaling pathway. Evid Based Complement Alternat Med 2013; 2013: 802784.
11. Liu X, Gu J, Fan Y., Shi H, Jiang M. Baicalin attenuates acute myocardial infarction of rats via mediating the Mitogen-activated protein kinase pathway. Biol Pharm Bull 2013; 36(6): 988-994.
12. Wu GL, Li Q. Research and prospect of the effective material basis of traditional Chinese medicine compound. Zhong Yi Yao Xin Xi 2007; 24(2): 27-29.
13. Yang YY, Yang ZC. Research progress on myocardial ischemia reperfusion injury protective agent. Shi Yong Yu Fang Yi Xue 2008; 15(2): 616-618.
14. Lv JJ, Wang ZX. The research progress of Chinese medicine prevented and treated myocardial ischemia-reperfu-sion injury by. Jiangsu Zhong Yi Yao 2012; 44(5): 76-77.
15. Yang WB. Efficacy observation of Yindanxinnaotong soft capsules combined with three chemicals for coronary disease angina pectoris. Zhong Guo Yao Fang 2010; 21(4): 370.
16. Hou FC. The clinical observation of Danshenchuanxiongqin injection combined with Yindanxinnaotong capsule to treat coronary heart disease and angina pectoris. Zhong Guo Xian Dai Yao Wu Ying Yong 2012; 6(8): 85-86.